Search - tctmd.com

Displaying 421 - 440 of 1502

Sort: Relevancy | Date

Presentation

Clinical Outcome of Titanium-Nitride-Oxide-Coated Cobalt-Chromium Stents

Presenter: Pasi P. Karjalainen

September 10, 2015

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

Presentation ESC 2015

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Presenter: G?rard Helft

August 31, 2015

Presentation

Incidence, Predictors, and Impact of Postdischarge Bleeding After PCI

Presenter: P. G?n?reux

August 28, 2015

Presentation

Stent Fracture After SES Implantation

Presenter: M. Ohya

August 28, 2015

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

Presentation

Differential Prognostic Effect of First- and Second-Generation DES in Coronary Bifurcation Lesions

Presenter: JM. Lee

August 25, 2015

Presentation CICT 2015

Drug Eluting Femoral Stents Where does it fit in my practice?

Presenter: Yazan Khatib

July 31, 2015

Presentation CICT 2015

Case Studies in Biodegradable Coronary Stent Implantation

Presenter: Antonio Colombo

July 31, 2015

Presentation

Relationship Between Stent Type and QoL Following PCI for Acute MI

Presenter: Adnan K. Chhatriwalla

July 30, 2015

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

Presentation

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Presenter: Pieter C. Smits

July 29, 2015

Presentation

Improved Outcomes of Elderly Patients Treated With DES vs BMS in Large Coronary Arteries

Presenter: David J. Kruz

July 28, 2015

Presentation

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Presenter: Mohamed Abdel-Wahab

July 23, 2015

Presentation

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

Presenter: J. Matthew Brennan

July 17, 2015

Presentation

High-Sensitivity C-Reactive Protein Predicts 10-Year Cardiovascular Outcome After PCI

Presenter: RM. Oemrawsingh

July 17, 2015

Presentation

PCI at Centers With and Without On-site Surgical Backup

Presenter: JM. Lee

July 15, 2015

Presentation

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Presenter: Sanjit S. Jolly

July 13, 2015

Presentation

Keynote Lecture I:Evolution of InterventionalTherapies and Future Directions

Presenter: Raoul Bonan

July 11, 2015

Presentation

Impact of Clinical Presentation on Long-term Outcomes in Women Undergoing PCI With DES

Presenter: G. Guistino

July 06, 2015

Advertisement

Clinical Outcome of Titanium-Nitride-Oxide-Coated Cobalt-Chromium Stents

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Incidence, Predictors, and Impact of Postdischarge Bleeding After PCI

Stent Fracture After SES Implantation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Differential Prognostic Effect of First- and Second-Generation DES in Coronary Bifurcation Lesions

Drug Eluting Femoral Stents Where does it fit in my practice?

Case Studies in Biodegradable Coronary Stent Implantation

Relationship Between Stent Type and QoL Following PCI for Acute MI

EES vs CABG for Patients With Diabetes and Multivessel Disease

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Improved Outcomes of Elderly Patients Treated With DES vs BMS in Large Coronary Arteries

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

High-Sensitivity C-Reactive Protein Predicts 10-Year Cardiovascular Outcome After PCI

PCI at Centers With and Without On-site Surgical Backup

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Keynote Lecture I:Evolution of InterventionalTherapies and Future Directions

Impact of Clinical Presentation on Long-term Outcomes in Women Undergoing PCI With DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content